Our aim is to collaborate with sponsors and help them design and conduct early stage clinical trials. netGEICAM focuses on phase IB and IIA trials that evaluate a new combination of drugs.
At the time, netGEICAM is formed of nine different hospitals, as listed below.
These hospitals have been selected after a deep analysis of their research record, infrastructure and their main researchers’ resumé.
netGEICAM is currently conducting two breast cancer studies and has two proposals in development, and the platform is open to drug research for other kinds of tumors.
The net is coordinated by GEICAM’s headquarters:
netGEICAM Director/GEICAM Chairman:
Dr. Miguel Martín – Head of the Medical Oncology Department Gregorio Marañón University Hospital, Madrid
Dr. Ander Urruticoechea – Scientific Director of Onkologikoa and member of its Breast Unit
Dr. Alberto Ocaña – Medical Oncology Department Albacete University Hospital, Albacete
Dra. Eva Carrasco – GEICAM Scientific Director
Dra. Susana Bezares – GEICAM Medical Lead